{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:51:27Z","timestamp":1789689087809,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100014538","name":"Lembaga Pengelola Dana Pendidikan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014538","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Indonesia Endowment Fund for Education","award":["20160222045506"],"award-info":[{"award-number":["20160222045506"]}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p\/>\n                  <jats:p>Surgical resection is one treatment modality for chronic pulmonary aspergillosis (CPA), and sometimes a preoperative presumption of lung cancer turns out to be CPA. We have audited our surgical experience with regard to risk factors for relapse, and the value of postoperative monitoring of Aspergillus-immunogolubulin G (IgG) titres.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>All patients with CPA surgically treated at National Aspergillosis Centre (NAC), Manchester, UK (2007\u20132018), were retrospectively evaluated. Surgical procedures, underlying disorders, Aspergillus-IgG titres (ImmunoCap) and antifungal therapy were evaluated for symptom control, operative complications, CPA relapse and mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 61 patients with CPA (28 males, 33 females) were operated on primarily for antifungal therapy failure (51%, n\u2009=\u200931) and presumed lung malignancies (38%, n\u2009=\u200923). Procedures included lobectomy (64%, n\u2009=\u200939), wedge resection (28%, n\u2009=\u200917), segmentectomy (n\u2009=\u20093), pneumonectomy (n\u2009=\u20093) and decortication (n\u2009=\u20092). Overall, 25 (41%) patients relapsed, 26 months (standard deviation: 24.8 months) after surgery. Antifungal therapy before surgery (P\u2009=\u20090.002) or both before and after surgery (P\u2009=\u20090.005) were protective for relapse. The relapse rate within 3\u2009years after surgery (33%, n\u2009=\u200920) was higher than the 3\u201310\u2009years after surgery (8%, n\u2009=\u20095). At the end of follow-up, the median Aspergillus-IgG titre was lower than at relapse in 12 patients (67 vs 126\u2009mg\/l) (P\u2009=\u20090.016).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Surgery in these selected patients with CPA resulted in favourable outcomes. Relapse is common after surgical treatment of CPA but can be minimized with antifungal therapy, emphasizing the importance of an accurate diagnosis prior to surgery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezaa137","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:09:50Z","timestamp":1585768190000},"page":"997-1003","source":"Crossref","is-referenced-by-count":34,"title":["Clinical outcomes of patients with chronic pulmonary aspergillosis managed surgically"],"prefix":"10.1093","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2763-3807","authenticated-orcid":false,"given":"Findra","family":"Setianingrum","sequence":"first","affiliation":[{"name":"Department of Parasitology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia"},{"name":"Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-6040","authenticated-orcid":false,"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK"},{"name":"National Aspergillosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Academic Health Science Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Shah","sequence":"additional","affiliation":[{"name":"Manchester Academic Health Science Centre, University of Manchester, Manchester, UK"},{"name":"Department of Cardiology and Cardiothoracic Surgery, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-2251","authenticated-orcid":false,"given":"David W","family":"Denning","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK"},{"name":"National Aspergillosis Centre, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Academic Health Science Centre, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2020102110251362600_ezaa137-B1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000362674","article-title":"Chronic pulmonary aspergillosis: an update on diagnosis and treatment","volume":"88","author":"Godet","year":"2014","journal-title":"Respiration"},{"key":"2020102110251362600_ezaa137-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"2020102110251362600_ezaa137-B3","year":"2015"},{"key":"2020102110251362600_ezaa137-B4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull World Health Org"},{"key":"2020102110251362600_ezaa137-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof2020018","article-title":"Chronic pulmonary aspergillosis\u2014where are we? And where are we going?","volume":"2","author":"Hayes","year":"2016","journal-title":"J Fungi"},{"key":"2020102110251362600_ezaa137-B6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"2020102110251362600_ezaa137-B7","first-page":"1","article-title":"A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention","volume":"73","author":"Godet","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020102110251362600_ezaa137-B8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000489474","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","volume":"96","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Respiration"},{"key":"2020102110251362600_ezaa137-B9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary aspergillosis in resource-limited settings: catalysing research and clinical care","volume":"24","author":"Denning","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2020102110251362600_ezaa137-B10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.athoracsur.2004.05.050","article-title":"Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma","volume":"79","author":"Kim","year":"2005","journal-title":"Soc Thorac Surg"},{"key":"2020102110251362600_ezaa137-B11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1749-8090-8-180","article-title":"Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence\u2014a National Centre\u2019s experience","volume":"8","author":"Farid","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"2020102110251362600_ezaa137-B12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2013.10.050","article-title":"Surgical therapy of pulmonary aspergillomas: a 30-year north American experience","volume":"97","author":"Muniappan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2020102110251362600_ezaa137-B13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejcts.2008.06.049","article-title":"Surgical outcome of pulmonary aspergilloma","volume":"34","author":"Brik","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"2020102110251362600_ezaa137-B14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/icvts\/ivu069","article-title":"Adjuvant antifungal therapy after pulmonary surgery for aspergilloma: is it useful?","volume":"18","author":"Benhamed","year":"2014","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2020102110251362600_ezaa137-B15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3906\/sag-1401-165","article-title":"Surgical management of pulmonary aspergilloma: clinical experience with 77 cases","volume":"45","author":"Aydo\u011fdu","year":"2015","journal-title":"Turk J Med Sci"},{"key":"2020102110251362600_ezaa137-B16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-94-007-4546-9_29","article-title":"Pulmonary aspergillosis: therapeutic management and prognostic factors from 16 years of monocenter experience","volume":"755","author":"Pabst","year":"2013","journal-title":"Respir Regul Clin Adv"},{"key":"2020102110251362600_ezaa137-B17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0003-4975(99)01334-X","article-title":"Aspergilloma: a series of 89 surgical cases","volume":"69","author":"Regnard","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"2020102110251362600_ezaa137-B18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1510\/icvts.2011.265553","article-title":"Surgery for aspergilloma: time trend towards improved results?","volume":"13","author":"Lejay","year":"2011","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2020102110251362600_ezaa137-B19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.athoracsur.2010.02.037","article-title":"Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy","volume":"89","author":"Sagan","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2020102110251362600_ezaa137-B20","first-page":"3671","article-title":"Clinical profile and surgical outcome for different types of chronic pulmonary aspergillosis","volume":"11","author":"He","year":"2019","journal-title":"Am J Transl Res"},{"key":"2020102110251362600_ezaa137-B21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/tri.12895","article-title":"Five myths about variable selection","volume":"30","author":"Heinze","year":"2017","journal-title":"Transpl Int"},{"key":"2020102110251362600_ezaa137-B22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"2020102110251362600_ezaa137-B23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"2020102110251362600_ezaa137-B24","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.clinpr.2020.100015","article-title":"Clinical infection in practice risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy","volume":"5","author":"Bongomin","year":"2020","journal-title":"Clin Infect Pract"},{"key":"2020102110251362600_ezaa137-B25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12893-015-0103-4","article-title":"Lung resection in pulmonary aspergilloma: experience of a Moroccan center vascular and thoracic surgery","volume":"15","author":"El Hammoumi","year":"2015","journal-title":"BMC Surg"},{"key":"2020102110251362600_ezaa137-B26","first-page":"99","article-title":"Surgical treatment for pulmonary aspergilloma\u2014early and long-term results","volume":"2","author":"Kasprzyk","year":"2017","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"2020102110251362600_ezaa137-B27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/thx.52.9.810","article-title":"Surgical treatment for pulmonary aspergilloma: a 28 year experience","volume":"52","author":"Chen","year":"1997","journal-title":"Thorax"},{"key":"2020102110251362600_ezaa137-B28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2169\/internalmedicine.39.209","article-title":"Clinical evaluation of 61 patients with pulmonary aspergilloma","volume":"39","author":"Kawamura","year":"2000","journal-title":"Intern Med"},{"key":"2020102110251362600_ezaa137-B29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejcts.2005.02.008","article-title":"Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplasty","volume":"27","author":"Gebitekin","year":"2005","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/58\/5\/997\/33976693\/ezaa137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/58\/5\/997\/33976693\/ezaa137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T14:25:37Z","timestamp":1603290337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/58\/5\/997\/5835265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,9]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezaa137","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,5,9]]}}}